Clinical Trial

Central Line-Associated Bloodstream Infection QI Project

Study acronym: CLABSI
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates a daily electronic health record (EHR) alert designed to reduce unnecessary central venous catheter (CVC) use among hospitalized adults. The alert identifies patients with an active CVC and no documented indication, prompting the first-contact provider to document line necessity. The study compares alert and a secure chat intervention to usual care, with the goal of reducing unnecessary line days and related CLABSI risk.
Trial Details
NCT Number NCT07746674
Lead Sponsor NYU Langone Health
Conditions Central Line-associated Bloodstream Infection (CLABSI)
Enrollment 30 participants
Start Date 2026-09
Primary Completion 2026-09 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-08-05